Navigation Links
EUSA Pharma Completes Acquisition Of Cytogen Corporation
Date:5/9/2008

DOYLESTOWN, Pennsylvania and OXFORD, England, May 9 /PRNewswire/ -- EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has completed its acquisition of Cytogen Corporation, following the approval of Cytogen's shareholders at a special meeting on 8 May.

Under the terms of the acquisition agreement, Cytogen shareholders will receive $0.62 per share, valuing the company at $22.6 million. To meet the consideration, EUSA has raised over $50 million in an investment round led by TVM Capital and supported by EUSA's existing investors, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. EUSA will now apply to delist all Cytogen's issued shares from the NASDAQ stock exchange.

Cytogen brings to EUSA three oncology and pain control products, a US specialty sales force and an established commercial infrastructure. With the completion of the acquisition, Cytogen will form a wholly-owned subsidiary of EUSA and will operate under the EUSA name.

"Completing our acquisition of Cytogen is particularly significant for EUSA as it also completes our transatlantic growth platform, positioning us as a partner of choice for further acquisitions and product in-licensing," said Bryan Morton, Chief Executive of EUSA Pharma. "We now have a strong US commercialization infrastructure to match our organization in Europe, which covers over 20 countries. We plan to rapidly integrate the Cytogen organization, allowing us to compete with major players as we accelerate our search for additional specialty products to leverage our infrastructure on both sides of the Atlantic. With a growing portfolio of medicines, we plan to begin exploiting our transatlantic platform with the launch of our US product Caphosol(R) in several European territories."

About EUSA Pharma Inc

EUSA Pharma is a rapidly growing transatlantic
'/>"/>

SOURCE EUSA Pharma Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... and even the entire body to visualize long-range connections ... been a long-time dream of biologists. A study published ... journal Cell has now made that dream ... bodies, and human tissue biopsies transparent, while keeping the ... the way for a better understanding of brain-body interactions, ...
(Date:7/31/2014)... July 31, 2014 The SNIS Foundation ... $25,000 to fund a translational research project.  The ... the gift was presented at the Society of ... in Colorado Springs, CO. ... approaches to neurovascular conditions, SNIS formed the SNIS ...
(Date:7/31/2014)... 31, 2014 Graphite Metallizing Corporation announces ... oven carts. These bearings are uniquely suited to prevent ... bearings because of the high temperatures . , ... from the design engineers at Graphite Metallizing to overcome ... During their manufacturing operation, pans containing blocks of powder ...
(Date:7/31/2014)... 31, 2014 Research and Markets ... Market 2014-2018" report to their offering. ... the study of the genetic material or genomes of ... basis for the discovery and development of diagnostic and ... health conditions. Genomics is supported by three major product ...
Breaking Biology Technology:See-through organs and bodies will accelerate biomedical discoveries 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2
... SYDNEY, Australia, Oct. 3 /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company Pharmaxis ... present 12 abstracts from its respiratory disease,program at ... held,in Berlin from the 4th to the 8th ... top respiratory researchers and clinicians to hear latest,advances ...
... 2 Alba Therapeutics Corporation today,announced the promotions of ... Mark Ginski, PhD, and Kate Huber. "We are pleased,to ... and we are,fortunate to have such a fine group ... for unmet medical needs of patients with celiac,disease, asthma, ...
... FOR LEAD DRUG CANDIDATE ARIKACE(TM) DRIVES,CONTINUED CLINICAL EXPANSION, ... Inc., a,biopharmaceutical company focused on developing innovative inhaled,pharmaceuticals ... announced that it has secured a $12.5 million ... Company LLC, an affiliate of Horizon,Technology Finance Management ...
Cached Biology Technology:Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 2Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 3Alba Therapeutics Corporation Announces Promotions 2Alba Therapeutics Corporation Announces Promotions 3Alba Therapeutics Corporation Announces Promotions 4Transave, Inc. Secures $12.5 Million in New Financing 2Transave, Inc. Secures $12.5 Million in New Financing 3Transave, Inc. Secures $12.5 Million in New Financing 4Transave, Inc. Secures $12.5 Million in New Financing 5
(Date:7/31/2014)... University researchers have completed a 20-year study that ... prairie at different times of the year. It ... spring time frame has no measurable negative consequences ... multiple benefits. , The study was conducted by ... Biological Station fire chief, and Joseph Craine, research ...
(Date:7/31/2014)... to loud noise alters how the brain processes ... sounds, according to neuroscientists at The University of ... this week in Ear and Hearing , ... hearing loss affects the brain,s recognition of speech ... corners of the population, affecting an estimated 15 ...
(Date:7/31/2014)... Oren Tessler, Assistant Professor of Clinical Surgery at LSU ... part of a team of plastic and reconstructive surgeons ... to screen and select patients for a specific surgical ... who underwent this surgery to decompress the nerves that ... cosmetic eyelid surgery. The study, which confirms the benefit ...
Breaking Biology News(10 mins):Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3UT Dallas study reveals effect of loud noises on brain 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2
... UTRECHT, The Netherlands, September 10 , ... Powers Privacy-Enhancing Biometric,Technology , WCC ... search,and match software, today announced its collaboration with priv-ID, ... anonymity for,the user. The collaboration will provide enhanced identification ...
... , , , , ... leader in fingerprint identity and authentication solutions, today announced that ... fingerprint sensor as an option on NCR,s next-generation integrated point-of-sale (POS) ... The fingerprint sensor, which is embedded in the top ...
... , , BEDFORD, ... ), a global provider of imaging and biometrics software, today ... development services to Lockheed Martin,s high-performance fingerprint card scanning service. ... Martin a five-year, $47 million contract to continue managing the ...
Cached Biology News:WCC Smart Search & Match and Priv-ID Announce Global Collaboration 2WCC Smart Search & Match and Priv-ID Announce Global Collaboration 3NCR Embeds DigitalPersona U.are.U(R) 4500HD Fingerprint Sensor in New NCR RealPOS(TM) 70XRT Point-of-Sale Workstations 2Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning 2Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning 3
... Y2 Receptor antiserum This NPY Y2 ... level and is currently being characerized in brain. ... and mouse and appears to work better on ... rat. For full characterizarion in dorsal root ganglion ...
RECK (F-20)...
Black Polypropylene 384 Round Well Plate 70/Box...
... 1 Peroxiredoxin (Prx) is a ... have been known to connect with ... isoforms (about 50 proteins), collected in ... homology, particularly amino-terminal region containing active ...
Biology Products: